N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine- induced contact allergy

British Journal of Dermatology

Volumn 142, Issue 6, 2000, Pages 1121-1127

  Westphal, Götz A ^b   Reich, K ^a   Schulz, T G ^b   Neumann, C ^a   Hallier, E ^b   Schnuch, A ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NONE

Author keywords

Contact dermatitis; Enzyme polymorphism; Immune response; N acetyltransferase

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE;

ACETYLATION; ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 8P; CONTACT ALLERGY; CONTACT DERMATITIS; CONTACT SENSITIZATION; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SKIN ALLERGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; DERMATITIS, CONTACT; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; ISOENZYMES; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0034131047     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03536.x     Document Type: Article

References (45)

1. 1 Merk HF, Jugert FK, Frankenberg S. Biotransformation in the skin. In: Dermatotoxicology (Marzulli FN, Maibach III, eds), 5th edn. Washington DC: Taylor & Francis, 1996: 61-73.
2. 2 Pumford NR, Halmes NC. Protein targets of xenobiotic reactive intermediates. Annu Rev Pharmacol Toxicol 1997; 37: 91-117.
3. 3 Scholes EW, Pendlington RU, Sharma RK, Basketter DA. Skin metabolism of contact allergens. Toxicol Vitro 1994; 8: 551-3.
4. 4 Hansen J, Möllgard B. Biotransformation of contact allergens in the skin. In: Immunological and Pharmacological Aspects of Atopic and Contact Eczema (Czernielewski JM, ed.), 4th edn, Vol. 4. Basel: Karger, 1991: 89-93.
5. 5 West WL, Knight EM, Pradhan S, Hinds TS. Interpatient variability: genetic predisposition and other genetic factors. J Clin Pharmacol 1997; 37: 635-48.
6. 6 Grant DM, Hughes NC, Janexic SA et al. Human acetyltransferase polymorphisms. Mutat Res 1997; 376: 61-70.
7. 7 Thygesen P, Risch A, Stacey M et al. Genes for human arylamine N-acetyltransferase in relation to loss of the short arm of chromosome 8 in bladder cancer. Pharmacogenetics 1999; 9: 1-8.
8. 8 Cascorbi I, Drakoulis N, Brockmöller J et al. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 1995; 57: 581-92.
9. 9 Cascorbi I, Brockmöller J. Bauer S et al. NAT2*12a (803A→G) codes for rapid arylamine N-acetylation in humans. Pharmacogenetics 1996; 6: 257-9.
10. 10 Bell DA, Stephens EA, Castranio T et al. Polyadenylation polymorphism in the acetyltransferase I gene (NAT1) increases risk of colorectal cancer. Cancer Res 1995; 55: 3537-42.
11. 11 Chen J, Stampfer MJ, Hough HI, et al. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 1998; 58: 3307-11.
12. 12 Cascorbi I, Brockmöller J, Mrozikiewicz PM et al. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 1996; 56: 3961-6.
13. 13 Nakamura II, Uetrecht J, Cribb AE et al. In vitro formation, disposition and toxicity of N-acetoxy-sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity. J Pharmacol Exp Ther 1995; 274: 1099-104.
14. 14 Bandmann O, Vaughan J, Holmans P et al. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 1997; 350: 1136-9.
15. 15 Rocha L, Garcia C, de Mendonca A et al. N-acetyltransferase (NAT2) genotype and susceptibility to sporadic Alzheimer's disease. Pharmacogenetics 1999; 9: 9-15.
16. 16 Schnuch A, Geier J, Uter W et al. National rates and regional differences in sensitization to allergens of the standard series. Population-adjusted frequencies of sensitization (PAFS) in 40,000 patients from a multicenter study (IVDK). Contact Dermatitis 1997; 37: 200-9.
17. 17 Reich K, Westphal GA, Schulz TG et al. Combined analysis of polymorphisms of the tumour necrosis factor-α and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 1999: 113: 214-20.
18. 18 Uter W, Schnuch A, Geier J, Frosch PJ. The Information Network of Departments of Dermatology (IVDK) in Germany. Eur J Dermatol 1998; 8: 36-40.
19. 19 Fregert S. Manual of Contact Dermatitis, 2nd edn. Copenhagen: Munksgaard, 1981.
20. 20 Miller SA, Dykes DD, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215-17.
21. 21 Bell DA, Stephens EA, Castranio T et al. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 1995; 55: 5226-9.
22. 22 Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. New York: Van Nostrand Reinhold, 1982: 284-306.
23. 23 Ott J. Analysis of Human Genetic Linkage. Baltimore: Johns Hopkins University Press, 1992: 633.
24. 24 Menné T, Holm NV. Genetic susceptibility in human allergic contact sensitization. Semin Dermatol 1986; 5: 301-6.
25. 25 Emtestam L, Carlsson B, Marcusson JA et al. Specificity of HLA restricting elements for human nickel reactive T cell clones. Tissue Antigens 1989; 33: 531-41.
26. 26 Emtestam L, Olerup O. On T-cell recognition of nickel as a hapten. Acta Derm Venereol (Stockh) 1996; 76: 344-7.
27. 27 Emtestam L, Zetterquist H, Olerup O. HLA-DR, DQ and -DP alleles in nickel, chromium, and/or cobalt-sensitive individuals: genomic analysis based on restriction fragment length polymorphisms. J Invest Dermatol 1993; 100: 271-4.
28. 28 Basketter DA, Liden C. Further investigation of the prohapten concept: reactions to benzene derivatives in man. Contact Dermatitis 1992; 27: 90-7.
29. 29 Basketter DA. Skin sensitization to cinnamic alcohol: the role of skin metabolism. Acta Derm Venereol (Stockh) 1992; 72: 264-5.
30. 30 Kerb R, Brockmöller J, Reum T, Roots I. Deficiency of glutathione S-transferase TI and MI as heritable factors of increased cutaneous UV sensitivity. J Invest Dermatol 1997; 108: 229-32.
31. 31 Brockmöller J, Cascorbi I, Kerb R et al. Polymorphisms in xenobiotic conjugation and disease predisposition. Toxicol Lett 1998; 28: 102-3, 173-83.
32. 32 Smelt VA, Mardon HJ, Sim E. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2. Pharmacol Toxicol 1998; 83: 149-57.
33. 33 Probst MR, Blum M, Fasshauer I et al. The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo[4, 5-f]quinoline (IQ). Carcinogenesis 1992; 13: 1713-17.
34. 34 Feng Y, Jiang W, Hein DW. 2-Aminofluoreine-DNA adduct levels in tumor-target and nontarget organs of rapid and slow acetylator Syrian hamsters congenic at the NAT2 locus. Toxicol Appl Pharmacol 1996; 141: 248-55.
35. 35 Kawakubo Y, Nakamori M, Schöpf E, Ohkido M. Acetylator phenotype in patients with p-phenylenediamine allergy. Dermatol 1997; 195: 43-5.
36. 36 Henning S, Cascorbi I, Munchow B et al. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk. Pharmacogenetics 1999; 9: 103-11.
37. 37 Rothmann KJ, Greenland S. Modern Epidemiology, 2nd edn. Philadelphia: Lippincott Raven, 1998: 225-7.
38. 38 Zielinska E, Niewiarowski W, Bodalski J et al. Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases. Clin Pharmacol Ther 1997; 62: 635-42.
39. 39 Gawronska-Szklarz B, Luszawska-Kutrzeba T, Czaja-Bulsa G, Kurzawski G. Relationship between acetylation polymorphism and risk of atopic diseases. Clin Pharmacol Ther 1999; 65: 62-9.
40. 40 Heule F, Tahapary GJ, van Bello CR, Joost T. Delayed-type hypersensitivity to contact allergens in psoriasis. A clinical evaluation. Contact Dermatitis 1998; 38: 78-82.
41. 41 Guillet MH, Guillet G. Allergologic survey in 251 patients with moderate or severe dermatitis. Incidence and value of the detection of contact eczema, food allergy or sensitization to airborne allergens. Ann Dermatol Venereol 1996; 123: 157-64.
42. 42 Nielsen NH, Menné T. Allergic contact sensitization in an unselected Danish population. The Glostrup Allergy Study, Denmark. Acta Derm Venereol (Stockh) 1992; 72: 456-60.
43. 43 Kempkes M, Wiebel FA, Golka K et al. Comparative genotyping and phenotyping of glutathione S-transferase GSTTI. Arch Toxicol 1996; 70: 306-9.
44. 44 Bell DA, Taylor JA, Paulson DF et al. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase MI (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85: 1159-64.
45. 45 Day CP, Grove J, Daly AK et al. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 1998; 41: 430-4.